Laurie D. De Leve, MD, PhD

Dr. DeLeve’s clinical interests include general gastroenterology, colon cancer screening, irritable bowel syndrome, drug-induced liver disease. Her research interests include the role of liver sinusoidal endothelial cell in liver injury recovery and liver fibrosis and drug-induced liver injury.

Born in New York City and raised in the Netherlands, Dr. DeLeve obtained a PhD in Pharmacology from the University of Toronto after receiving her medical degree from the Erasmus University of Rotterdam. Following her residency at the University of Michigan and fellowship at UCLA, Dr. DeLeve joined the Keck School of Medicine as an Assistant Professor in 1990.

• Alpha Omega Alpha: Teaching Award, 2005
• Western Society for Clinical Investigation: Outstanding Investigator Award, 2008
• USC: Mellon Mentoring Award for Faculty Mentoring Faculty, 2015

• Liver Sinusoidal Endothelial Cell Progenitor Cells (sprocs) and Chronic Liver Disease
  NIH · R01DK100580 · Aug 1, 2014 – Dec 31, 2024 · Role: Principal Investigator
• Determinants of Sinusoidal Endothelial Cell Phenotype.
  NIH · R01DK066423 · Aug 15, 2003 – Jun 30, 2012 · Role: Principal Investigator
• Liver Sinusoidal Endothelial Cell Progenitor Cells.
  NIH · R01DK046357 · Jan 1, 1994 – Mar 31, 2019 · Role: Principal Investigator
• MECHANISMS OF TOXICITY IN SINUSOIDAL ENDOTHELIAL CELLS
  NIH · R29DK046357 · Jan 1, 1994 – Dec 31, 1998 · Role: Principal Investigator

• Kaplowitz, Neil
• Tsukamoto, Hidekazu
• Terrault, Norah
• Zlokovic, Berislav
• Wood, John
• Fernandez-Checa Torres, Jose